vs
Side-by-side financial comparison of FIRST BUSEY CORP (BUSE) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
FIRST BUSEY CORP is the larger business by last-quarter revenue ($196.2M vs $185.2M, roughly 1.1× AMICUS THERAPEUTICS, INC.). FIRST BUSEY CORP runs the higher net margin — 25.5% vs 0.9%, a 24.6% gap on every dollar of revenue. Over the past eight quarters, FIRST BUSEY CORP's revenue compounded faster (29.9% CAGR vs 29.5%).
First Busey Bank is a financial institution headquartered in Champaign, Illinois that operates in Illinois, Indiana, and southwest Florida. It is owned by First Busey Holding, a financial holding company.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BUSE vs FOLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.2M | $185.2M |
| Net Profit | $50.0M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | — | 8.6% |
| Net Margin | 25.5% | 0.9% |
| Revenue YoY | — | 23.7% |
| Net Profit YoY | 266.7% | -88.5% |
| EPS (diluted) | $1.00 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $196.2M | — | ||
| Q4 25 | $200.2M | $185.2M | ||
| Q3 25 | $196.3M | $169.1M | ||
| Q2 25 | $198.0M | $154.7M | ||
| Q1 25 | $125.0M | $125.2M | ||
| Q4 24 | $116.8M | $149.7M | ||
| Q3 24 | $118.5M | $141.5M | ||
| Q2 24 | $116.2M | $126.7M |
| Q1 26 | $50.0M | — | ||
| Q4 25 | — | $1.7M | ||
| Q3 25 | $57.1M | $17.3M | ||
| Q2 25 | $47.4M | $-24.4M | ||
| Q1 25 | $-30.0M | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $32.0M | $-6.7M | ||
| Q2 24 | $27.4M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% |
| Q1 26 | — | — | ||
| Q4 25 | 38.7% | 8.6% | ||
| Q3 25 | 39.4% | 20.3% | ||
| Q2 25 | 32.6% | -6.1% | ||
| Q1 25 | -26.1% | -6.3% | ||
| Q4 24 | 32.0% | 10.7% | ||
| Q3 24 | 35.9% | 15.3% | ||
| Q2 24 | 33.1% | 11.8% |
| Q1 26 | 25.5% | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | 29.1% | 10.2% | ||
| Q2 25 | 23.9% | -15.8% | ||
| Q1 25 | -24.0% | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | 27.0% | -4.8% | ||
| Q2 24 | 23.5% | -12.4% |
| Q1 26 | $1.00 | — | ||
| Q4 25 | $0.81 | $0.00 | ||
| Q3 25 | $0.58 | $0.06 | ||
| Q2 25 | $0.52 | $-0.08 | ||
| Q1 25 | $-0.44 | $-0.07 | ||
| Q4 24 | $0.50 | $0.05 | ||
| Q3 24 | $0.55 | $-0.02 | ||
| Q2 24 | $0.47 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $288.5M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $2.5B | $274.2M |
| Total Assets | $18.1B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $288.5M | — | ||
| Q4 25 | $294.1M | $293.5M | ||
| Q3 25 | $385.5M | $263.8M | ||
| Q2 25 | $752.4M | $231.0M | ||
| Q1 25 | $1.2B | $250.6M | ||
| Q4 24 | $697.7M | $249.9M | ||
| Q3 24 | $553.7M | $249.8M | ||
| Q2 24 | $285.3M | $260.1M |
| Q1 26 | — | — | ||
| Q4 25 | $113.8M | $392.7M | ||
| Q3 25 | $92.4M | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | $0 | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $274.2M | ||
| Q3 25 | $2.4B | $230.4M | ||
| Q2 25 | $2.4B | $204.3M | ||
| Q1 25 | $2.2B | $193.6M | ||
| Q4 24 | $1.4B | $194.0M | ||
| Q3 24 | $1.4B | $178.8M | ||
| Q2 24 | $1.3B | $132.5M |
| Q1 26 | $18.1B | — | ||
| Q4 25 | $18.1B | $949.9M | ||
| Q3 25 | $18.2B | $868.8M | ||
| Q2 25 | $18.9B | $815.3M | ||
| Q1 25 | $19.5B | $789.8M | ||
| Q4 24 | $12.0B | $785.0M | ||
| Q3 24 | $12.0B | $786.6M | ||
| Q2 24 | $12.0B | $749.5M |
| Q1 26 | — | — | ||
| Q4 25 | 0.05× | 1.43× | ||
| Q3 25 | 0.04× | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | 0.00× | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $192.6M | $16.3M | ||
| Q3 25 | $62.5M | $35.7M | ||
| Q2 25 | $49.5M | $-26.5M | ||
| Q1 25 | $8.4M | $7.8M | ||
| Q4 24 | $178.3M | $-3.9M | ||
| Q3 24 | $60.1M | $-23.0M | ||
| Q2 24 | $28.5M | $22.7M |
| Q1 26 | — | — | ||
| Q4 25 | $173.0M | $16.0M | ||
| Q3 25 | $54.5M | $35.3M | ||
| Q2 25 | $46.1M | $-28.9M | ||
| Q1 25 | $6.6M | $7.5M | ||
| Q4 24 | $171.8M | $-4.2M | ||
| Q3 24 | $59.1M | $-23.3M | ||
| Q2 24 | $26.3M | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | 86.4% | 8.6% | ||
| Q3 25 | 27.7% | 20.9% | ||
| Q2 25 | 23.3% | -18.7% | ||
| Q1 25 | 5.3% | 6.0% | ||
| Q4 24 | 147.1% | -2.8% | ||
| Q3 24 | 49.9% | -16.5% | ||
| Q2 24 | 22.6% | 17.0% |
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 0.2% | ||
| Q3 25 | 4.1% | 0.2% | ||
| Q2 25 | 1.7% | 1.6% | ||
| Q1 25 | 1.4% | 0.2% | ||
| Q4 24 | 5.5% | 0.2% | ||
| Q3 24 | 0.8% | 0.3% | ||
| Q2 24 | 1.9% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.62× | ||
| Q3 25 | 1.09× | 2.06× | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 1.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BUSE
| Net Interest Income | $154.0M | 78% |
| Noninterest Income | $42.3M | 22% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
